In vivo transgenic mutation assays

Environmental and Molecular Mutagenesis

Volumn 35, Issue 3, 2000, Pages 253-259

  Heddle, John A ^a   Dean, Stephen ^b   Nohmi, Takehiko ^c   Boerrigter, Michaël ^d   Casciano, Daniel ^e   Douglas, George R ^f   Glickman, Barry W ^g   Gorelick, Nancy J ^h   Mirsalis, Jon C ⁱ   Martus, Hans Jörg ^j   Skopek, Thomas R ^k   Thybaud, Veronique ^l   Tindall, Kenneth R ^m   Yajima, Nobuhiro ⁿ  

^a YORK UNIVERSITY   (Canada)

^b Research Toxicology Centre   (Italy)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d Leven Inc   (United States)

^e NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^f HEALTH CANADA   (Canada)

^g UNIVERSITY OF VICTORIA   (Canada)

^h PROCTER AND GAMBLE COMPANY   (United States)

ⁱ SRI INTERNATIONAL   (United States)

^j NOVARTIS PHARMA AG   (Switzerland)

^k MERCK RESEARCH LABORATORIES   (United States)

^l SANOFI   (France)

^m NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

ⁿ SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

more..

Author keywords

BigBlue mouse rat; lacl; lacZ; Muta(TM) Mouse; Transgenic mutation assays

Indexed keywords

ANIMAL CELL; COLONY FORMING UNIT; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; GENE LOCUS; GENE MUTATION; MAXIMUM PERMISSIBLE DOSE; MOUSE; NONHUMAN; RAT; RELIABILITY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; RATS; RATS, INBRED F344; SPECIMEN HANDLING;

ANIMALIA; RODENTIA;

EID: 0034033214     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(2000)35:3<253::AID-EM11>3.0.CO;2-J     Document Type: Conference Paper

References (48)

1. Adler I-D, Bootman J, Favor J, Hook G, Schriever-Schwemmer G, Welzl G, Whorton E, Yoshimura I, and Hayashi M. 1998. Recommendations for statistical designs of in vivo mutagenicity tests with regard to subsequent statistical analysis. Mutat Res 417:19-30.
2. Aidoo A, Lyn-Cook L, Mittelstaedt R A, Heflich R H and Casciano D A. 1991. Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ Mol Mutagen 17:141-151.
3. Boerrigter METI. 2000. Treatment of LacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies and mutant spectra. Environ Mol Mutagen 34:140-147.
4. Boerrigter METI, Vijg J. 1997. Sources of variability in mutant frequency determinations in different organs of lacZ plasmid-based transgenic mice: experimental features and statistical analysis. Environ Mol Mutagen 29:221-229.
5. Boerrigter METI, Dollé MET, Martus H-J, Gossen JA, Vijg J. 1995. Plasmid-based transgenic mouse model for studying in vivo mutations. Nature 377:657-659.
6. Brault D, Renault D, Tombolan F, Thybaud V. 2000. Kinetics of induction of DNA damage and LacZ gene mutations in stomach mucosa of mice treated with β-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and Muta™-Mouse models. Environ Mol Mutagen 34:182-189.
7. Burkhart JG, Winn RN, VanBeneden R, Malling HV. 1992. The *X174 bacteriophage shuttle vector for the study of mutagenesis. Environ Mol Mutagen 19(Suppl 20):8.
8. Butterworth BE, Templin MV, Constan AA, Sprankle CS, Wong BA, Pluta LJ, Everitt JI, Recio L. 1998. Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female. Environ Mol Mutagen 31:248-256.
9. Carr GJ, Gorelick NJ. 1995. Statistical design and analysis of mutation studies in transgenic mice. Environ Mol Mutagen 25:246-255.
10. Cosentino L, Heddle J A. 1996. A test for neutrality of mutations of the lacZ transgene. Environ Mol Mutagen 28:313-316.
11. Cosentino L, Heddle J A. 1999. A comparison of the effects of diverse mutagens at the lacZ and Dlb-I loci in vivo. Mutagenesis 14:113-119.
12. Dean SW, Brooks TM, Burlinson B, Mirsalis J, Myhr B, Recio L, Thybaud V. 1999. Transgenic mouse mutation assay systems can play an important role in regulatory testing in vivo for the detection of site-of-contact mutagens. Mutagenesis 14:141-145.
13. Dollé MET, Martus H-J, Gossen JA, Boerrigter METI, Vijg J. 1996. Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations. Mutagenesis 11:111-118.
14. Dollé MET, Giese H, Hopkins CL, Martus H-J, Hausdorff JM, Vijg J. 1997. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat Genet 17:431-434.
15. Dollé MET, Martus H-J, Novak M, van Orsouw NJ, Vijg J. 1999. Characterization of color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection. Mutagenesis 14:287-293.
16. Douglas G, Jiao J, Gingerich JR, Soper LM, Gossen JA. 1996. Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice. Environ Mol Mutagen 28:317-324.
17. Gorelick NJ. 1995. Overview of mutation assays in transgenic mice for routine testing. Environ Mol Mutagen 25:218-230.
18. Gossen JA, de Leeuw WJF, Tan CHT, Lohman PHM, Berends F, Knook DL, Zwarthoff EC, Vijg J. 1989. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci U S A 86:7981-7985.
19. Gossen JA, Martus H-J, Wei JY, Vijg J. 1995. Spontaneous and X-ray-induce deletion mutations in a lacZ plasmid-based transgenic mouse model. Mutat Res 331:89-97.
20. Hoorn AJW, Custer LL, Myhr BC, Brusick D, Gossen J, Vijg J. 1993. Detection of chemical mutagens using MutaMouse: a transgenic mouse model, Mutagenesis 8:7-10.
21. Jones IM, Burkhart-Shultz K, Carrano AV. 1985. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat Res 147:97-105.
22. RlacI shuttle vector in transgenic mice. Proc Natl Acad Sci U S A 88:7958-7962.
23. Manjanatha MG, Shelton SD, Aidoo A, Lyn-Cook LE, Casciano DA. 1998. Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene in Big Blue™ rats treated with 7,12-dimethylbenz[a]anthracene (DMBA). Mutat Res 401:165-178.
24. Masumura K, Matsui M, Kato M, Horiya N, Ueda O, Tanabe H, Yamada M, Suzuki H, Sofuni T, Nohmi T. 2000. Spectra of gpt mutations in ethylnitrosourea-treated and untreated transgenic mice. Environ Mol Mutagen (in press).
25. Mirsalis JC, Provost GS, Matthews CD, Hamner RT, Schindler JE, O'Loughlin KG, MacGregor JT, Short JM. 1993. Induction of hepatic mutations in lacI transgenic mice. Mutagenesis 8:265-271.
26. Mirsalis JC. 1995. Transgenic models for detection of mutations in tumors and normal tissues of rodents. Toxicol Lett 82:131-134.
27. Morrison V, Ashby J. 1994. A preliminary evaluation of the performance of the Muta™Mouse (lacZ) and Big Blue™ (lacI) transgenic mouse mutation assays. Mutagenesis 4:367-375.
28. - and 6-thioguanine selections. Environ Mol Mutagen 28:465-470.
29. - selection: an efficient method to detect γ-ray-induced deletions in transgenic mice. Environ Mol Mutagen (in press).
30. - selection. Environ Mol Mutagen (in press).
31. Paashuis-Lew Y, Zhang XB, Heddle JA. 1997. On the origin of spontaneous somatic mutations and sectored plaques detected in transgenic mice. Mutat Res 373:277-284.
32. Piegorsch WW, Lockhart AC, Carr GJ, Margolin BH, Brooks T, Douglas GR, Liegibel UM, Suzuki T, Thybaud V, van Delft JHM, Gorelick NJ. 1997. Sources of variability in data from a positive selection lacZ transgenic mouse mutation assay: an interlaboratory study. Mutat Res 388:249-289.
33. Piegorsch WW, Margolin BH, Shelby MD, Johnson A, French JE, Tennant RW, Tindall KR. 1995. Study design and sample sizes for a lacI transgenic mouse mutation assay. Environ Mol Mutagen 25:231-245.
34. Skopek TR, Kort KL, Marino DR. 1995. Mutation of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue™ B6C3F1 mice. Environ Mol Mutagen 26:9-15.
35. Skopek TR, Kort KL, Marino DR, Mittal LV, Umbenhauer DR, Laws GM, Adams SP. 1996. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue™ B6C3F1 mice. Environ Mol Mutagen 28:376-384.
36. 6-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice. Environ Mol Mutagen 34:221-226.
37. Swiger RR, Cosentino L, Shima N, Heddle JA. 2000. Properties of the cII locus in the Muta™Mouse System. Environ Mol Mutagen 34:201-207.
38. Tao KS, Urlando C, Heddle JA. 1993a. Comparison of somatic mutation in a transgenic versus host locus. Proc Nail Acad Sci USA 90:10681-10685.
39. Tao KS, Urlando C, Heddle JA. 1993b. Mutagenicity of methyl methane-sulphonate (MMS) in vivo in the Dlb-I native locus and the LacI transgene. Environ Mol Mutagen 22:293-296.
40. Tao KS, Heddle JA. 1994. The accumulation and persistence of somatic mutations. Mutagenesis 9:187-191.
41. Tombolan F, Renault D, Brault D, Guffroy M, Périn-Roussel O, Périn F, Thybaud T. 1999a. Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta™Mice treated with 5,9-dimethyl-dibenzo[c,g]carbazole. Carcinogenesis 20:125-132.
42. Tombolan F, Renault D, Brault D, Guffroy M, Périn F, Thybaud T. 1999b. Effect of mitogenic or regenerative cell proliferation on lacZ mutant frequency in the liver of Muta™Mice treated with 5,9-dimethyl-dibenzo[c,g]carbazole. Carcinogenesis 20:1357-1362.
43. Vijg J, Douglas GR. 1996. Bacteriophage lambda and plasmid lacZ transgenic mice for studying mutations in vivo. In: Pfeifer GP, editor. Technologies for detection of DNA damage and mutation. New York: Plenum Press, p 391-410.
44. Walker VE, Gorelick NJ, Andrews JL, Craft TR, deBoer JG, Glickman BW, Skopek TR. 1996. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res 56:4654-4661.
45. Walker VE, Andrews JL, Upton PB, Skopek TR, deBoer JG, Walker DM, Shi X, Sussman HE, Gorelick NJ. 2000. Detection of cyclophosphamide-induced mutations at the hprt but not the lacI locus in splenic lymphocytes of exposed mice. Environ Mol Mutagen 34: 167-181.
46. Winton DJ, Blount MA, Ponder BAJ. 1988. A clonal marker induced by mutation in mouse intestinal epithelium. Nature 333:463-466.
47. Zhang XB, Urlando C, Tao KS, Heddle J A. 1995. Factors affecting somatic mutation frequencies in vivo. Mutat Res 338:189-201.
48. Zhang XB, Felton J, Tucker JD, Urlando C, Heddle JA. 1996. Intestinal mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and amino(α)carboline (AαC) in transgenic mice. Carcinogenesis 17:2259-2265.